Skip to content

The Effects of Lowering Dietary Carbohydrates on Health, Exercise Performance and Wellbeing-related Outcomes

The Effects of Lowering Dietary Carbohydrates on Health, Exercise Performance and Wellbeing-related Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03934476
Enrollment
100
Registered
2019-05-01
Start date
2018-09-01
Completion date
2020-12-31
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet Modification, Obesity

Keywords

ketogenic diet, carbohydrates, chronic diseases, physical activity, fatigue, mood, wellbeing

Brief summary

The aim of the study is to investigate the long-term effects of the ketogenic diet and exercise (including interactions) on health markers, exercise performance and wellbeing outcomes in sedentary overweight individuals.

Detailed description

Intentional nutritional ketosis induced by the low carbohydrate diet is an intensively discussed topic of many scientific as well as non-scientific discussions throughout the areas of healthy living, the sports sciences and often used now for the prevention and treatment of chronic diseases. It has been demonstrated that long-term low-carbohydrate diet is more effective for weight loss and cardiovascular and metabolic risk factor reduction than a low-fat diet. In light of conflicting theories of best practice surrounding a polarized topic that impacts human health and daily work performance, the primary aim of this research project is to examine how low-carbohydrate ketogenic diets affect health markers, exercise performance and wellbeing outcomes in sedentary overweight individuals. Each study subject will be randomized into one of the four arms of the study and will undergo a 12-week intervention, with the exception of the study subjects in the control group, who will undergo no intervention for the period of 12 weeks. The project outcomes are of immense importance for the investigator's global human health, focus on a unique holistic perspective and have the potential to contribute towards much-needed adjustments in public health recommendations.

Interventions

BEHAVIORALKetogenic diet

The study subjects randomized for this intervention will observe the ketogenic diet, as prescribed by the protocol.

BEHAVIORALExercise HIIT

The study subjects randomized for this intervention will observe the HIIT exercise programme, as prescribed by the protocol.

Sponsors

University of Ostrava
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

No masking will be used in this study.

Intervention model description

The study subjects will be randomized into four study groups, one of which will be the control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* BMI 25.00 - 40.00 kg/m2 * non-smokers * non-excessive alcohol intake (self-reported, ≥ to 2 drinks/day for men or ≥1 drink/day for women) * willing to accept random assignment * low active individuals over the last 1 year, i.e. no specific sports training or regular exercise (up to once a week) and self-reported physical activity \< 150 min/week (IPAQ) * no evidence of liver, renal, metabolic, and cardiopulmonary disease and dis-eases contraindicating physical activity, no cancer, no psychiatric illness * Physical Activity Readiness Questionnaire (PAR-Q) pass * body weight stable for the last 2 months and not actively on a weight loss plan * prediabetes state allowed (impaired fasting glucose level, i.e. 5.6 - 6.9 mmol/l; HbA1c 5.7 - 6.4 %)

Exclusion criteria

* pregnancy, lactation * any specific diet (e.g. vegetarian) * use of hypoglycemic, lipid-lowering, antihypertensive, psychiatric medications or medications known to affect body weight or energy expenditure; any medication not noted allowed if the individual had been stable while taking such medication for at least 3 months prior to baseline data collection

Design outcomes

Primary

MeasureTime frameDescription
Change in the time to exhaustion12 weeks (baseline + every four weeks)All study subjects will undergo the Graded Exercise Test, with measuring of the time to exhaustion in minutes.
Change in cardiorespiratory variables - oxygen consumption12 weeks (baseline + every four weeks)All study subjects will undergo the Graded Exercise Test, with measuring of the oxygen consumption (L/min).
Change in cardiorespiratory variables - heart rate12 weeks (baseline + every four weeks)All study subjects will undergo the Graded Exercise Test, with measuring of the heart rate (beats per minute).

Secondary

MeasureTime frameDescription
Anthropometrics - body weight12 weeks (baseline + every four weeks)All study subjects will undergo anthropometric assessment of the body weight, measured in kg.
Anthropometrics - waist circumference12 weeks (baseline + every four weeks)All study subjects will undergo anthropometric assessment of the waist circumference, measured in cm.
Biochemical analysis - capillary blood12 weeks (2 times/week)All study subjects will undergo biochemical analysis of capillary blood - βHB and fasting glukose in mmol/L.
InBody (bioimpedance)12 weeks (baseline + every four weeks)All study subjects will undergo antrhropometric assessment of bioimpedance using the InBody device showing the percentage of water and fat in the organism, measured in % of total body weight.
Anthropometrics - DXA12 weeks (baseline + outcome)All study subjects will undergo anthropometric assessment of DXA - total abdominal fat, measured in kg.
Biochemical analysis - venous blood12 weeks (2 times/week)All study subjects will undergo biochemical analysis of venous blood - oxidative stress, inflammation, total CHO, HDL, LDL, TG, FFA, GL, homocysteine, measured in mmol/L.
Anthropometrics - body height12 weeks (baseline + every four weeks)All study subjects will undergo anthropometric assessment of the body height, measured in cm.

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026